Integrum AB (publ)
INTEG-B.ST - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$225.34M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $225.34 Million |
|---|---|
| Enterprise Value | $213.08 Million |
| Earnings per Share | $-1.98 |
| Beta | 0.42 |
| Outstanding Shares | 26,667,910 |
Return
| Return on Equity | -20.38% |
|---|---|
| Return on Assets | -17.83% |
| Return on Invested Capital | -21.87% |
Valuation & Multiples
| P/E Ratio | -5.88 |
|---|---|
| PEG | 5.41 |
| Price to Sales | 2.81 |
| Price to Book Ratio | 1.4 |
| Enterprise Value to Revenue | 2.18 |
| Enterprise Value to EBIT | -5.56 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 3, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$31.00 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 3, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Integrum AB (publ)
33 employees
CEO: Martin Hillsten
Integrum AB (publ) focuses on the research, development, and global sale of advanced bone-anchored prosthetic solutions. A core offering is the Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant system. This inn...